Status:

WITHDRAWN

Combination Therapy With Camostat Mesilate + Hydroxychloroquine for COVID-19

Lead Sponsor:

Heinrich-Heine University, Duesseldorf

Collaborating Sponsors:

Universitätsklinikum Hamburg-Eppendorf

Goethe University

Conditions:

COVID

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

Evaluation of the efficacy and safety of hydroxychloroquine - camostat combination therapy in hospitalized patients with moderate COVID-19 infection, CLOCC-Trial Primary Objectives: The primary object...

Detailed Description

The ongoing pandemic with the novel coronavirus (SARS-CoV-2) poses a massive threat to public health. SARS-CoV-2 is highly contagious and may lead to severe acute respiratory distress syndrome in affe...

Eligibility Criteria

Inclusion

  • Participants ≥18 years of age with SARS-CoV-2 infection confirmed by PCR before randomization
  • Willing and able to provide written informed consent
  • Hospitalized and requiring medical care for COVID-19, (status 3 or 4 of 7-point ordinal clinical status scale)
  • SpO2 ≥93% on room air
  • Evidence of pulmonary infiltrate on chest X ray/and or CT scan

Exclusion

  • Age \<18 years old
  • Pregnant or breast feeding
  • Inability to take oral medication
  • Inability to provide informed written consent
  • Known hypersensitivity towards 4-aminoquinolines, e.g. hydroxychloroquine and/or camostat
  • Use of hydroxychloroquine, chloroquine and or camostat within 6 months prior to baseline
  • Patients with known retinopathy or macular degeneration Patients with known glucose-6-phosphate dehydrogenase (G6PD) deficiency
  • Prolonged QTc-interval in baseline ECG (\>500 ms)
  • Concomitant medication associated with QTc-interval prolongation, which cannot be withdrawn prior to study drug administration
  • Major comorbidities, possibly leading to increased unwanted side effects of study drugs:

Key Trial Info

Start Date :

May 1 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2021

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT04338906

Start Date

May 1 2020

End Date

December 1 2021

Last Update

December 21 2020

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.